Merck has signed a global development and commercialization deal worth $290 million with Orion Corporation for the latter’s investigational candidate ODM-208 and other drugs that target cytochrome P450 11A1 (CYP11A1). ODM-208, which is an oral, non-steroidal inhibitor of CYP11A1, is presently being assessed by the Finnish pharma company in a phase 2 clinical trial for […]
Infosys has been roped in by Orion Corporation, a Finnish pharma company, to transform its enterprise resource planning (ERP) and planning platforms, boost employee experience, and power business value realization. The Indian IT services provider said that it will adopt standardized best SAP practices to facilitate end-to-end visibility across Orion’s operations, informed decision making, and […]